Healthcare Triangle Signs LOI to Acquire Roboticom's Robotics Business

Key Facts

1Healthcare Triangle signed a non-binding Letter of Intent to acquire assets and intellectual property associated with Italy-based Roboticom.

2Roboticom management projections target $153.5 million in revenue by fiscal year 2029/30.

In a move reflecting the growing trend of integrating automation technologies into industrial and healthcare sectors, Healthcare Triangle (HCTI) has announced a preliminary agreement to expand its footprint. The company signed a non-binding Letter of Intent to acquire assets and intellectual property associated with Italy-based Roboticom, a provider of industrial robotic systems. According to reports, the acquisition targets precision automation business lines serving the aerospace, marine, and orthotics sectors, with management projections aiming for $153.5 million in revenue by fiscal year 2029/30.

The strategic expansion comes as tech firms seek to bolster their intellectual property portfolios in advanced robotics, with Roboticom offering specialized solutions under brands such as SandRob and ScultoRob. Per market data, HCTI shares closed at $0.8647 on September 22, 2026, having reached a day high of $0.87. The financial projections provided by Roboticom management also target an adjusted operating contribution of $64 million by 2030, though these figures remain unaudited and subject to significant uncertainty.

Traders should watch for the transition of this non-binding LOI into a definitive agreement as the primary catalyst for the stock. At close on September 22, 2026, HCTI was priced at $0.8647, maintaining a range above its daily low of $0.7801. With no major upcoming corporate events listed in the immediate calendar, the progress of this acquisition and the verification of Roboticom's financial targets will remain the central focus for market participants.